More fears for pharma IP rights in India as Novartis heads for the Supreme Court

India’s attitude towards pharmaceutical patents comes under the spotlight once again this week as Swiss multinational Novartis heads for the Supreme Court in Delhi in a last-ditch attempt to attain patent protection for its cancer drug Glivec…

Get unlimited access to all IAM content